Ever Source Wealth Advisors, LLC Axsome Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 259 shares of AXSM stock, worth $28,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
259
Previous 178
45.51%
Holding current value
$28,660
Previous $15,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AXSM
# of Institutions
409Shares Held
36.6MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$429 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$365 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$323 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$187 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$108 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.74B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...